Chemoinformaics analysis of (5Z)-5-[(Z)-HEX-4-EN-2-YNYLIDENE]FURAN-2-ONE
| Molecular Weight | 160.172 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 1 |
| Exact Molecular Weight | 160.052 | nRing | 1 |
| Solubility: LogS | -3.2 | nHRing | 1 |
| Solubility: LogP | 3.946 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 23.6383 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.485 |
| Synth | 1.783 |
| Natural Product Likeliness | 0.575 |
| NR-PPAR-gamma | 0.957 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.045 |
| Pgp-sub | 0.001 |
| HIA | 0.011 |
| CACO-2 | -5.234 |
| MDCK | 0.0000386 |
| BBB | 0.833 |
| PPB | 0.945629 |
| VDSS | 0.408 |
| FU | 0.024862 |
| CYP1A2-inh | 0.07 |
| CYP1A2-sub | 0.174 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.125 |
| CYP2c9-sub | 0.979 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.065 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.022 |
| CL | 3.279 |
| T12 | 0.794 |
| hERG | 0.03 |
| Ames | 0.005 |
| ROA | 0.022 |
| SkinSen | 0.854 |
| Carcinogencity | 0.112 |
| EI | 0.983 |
| Respiratory | 0.232 |
| NR-Aromatase | 0.086 |
| Antiviral | No |
| Prediction | 0.903106 |